Product Details:
| Minimum Order Quantity | 1 Stripe |
| Packaging Size | Megestrol Acetate in India |
| Brand | Oncostrol - 160 |
| Composition | Megestrol Acetate Tablets IP-160 mg |
| Manufacturer | SHARING FORMULATIONS PVT LTD |
| Treatment | Megestrol Acetate in India |
| Prescription/Non prescription | Prescription |
| Packaging Type | Strips |
| Form | Tablet |
| Shelf life | 2 Year |
| Strength | 160 mg |
| Pack Size | 3*10 Tablet |
| Type Of Medicines | Allopathic |
| Application | Anti Cancer |
Maruti Agency is marketing Megestrol Acetate Tablets IP in India.
Megestrol Acetate in India
Additional Information:
Product Details:
| Minimum Order Quantity | 3 Pack |
| Dosage Form | Tablet |
| Composition | Piper Nigrum-5 mg,Astaxanthin-2mg,95% Curcumin-125 mg |
| Packaging Size | 3 x 10 Tablets |
| Packaging Type | Alu Alu Strip Packing |
| Shelf life | 18 months |
| Active Ingredient | Curcumin,Piper Nigrum,Astaxanthin |
| Usage/Application | Hospital and Clinic |
| Brand | Qxanthin - P |
| Country of Origin | Made in India |
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Packaging Type | bottle |
| Packaging Size | 30 Tablet |
| Manufacturer | Gleanmark Pharma |
| Usage | Hospital |
| Prescription/Non prescription | Prescription |
| Brand | Glenmark |
| Medicine Type | Allopathic |
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Bottle |
| Prescription/Non prescription | Prescription |
| Shelf life | 2 Years |
| Form | Tablet |
| Country of Origin | Made in India |
| Application | Anti Cancer |
| Uses | Hospital,Clinical |
| Packaging Size | 25 Tablet |
| Brand | Halsted Pharma Pvt. Ltd. |
Additional Information:
Product Details:
| Minimum Order Quantity | 10 Stripe |
| Dose/Strength | 8 mg, As Directed by physician |
| Brand | Ultigo-8 MD |
| Packaging Size | 10 x 10 Tablets |
| Packaging Type | Strip |
| Active Ingredient | Ondansetron |
| Composition | Ondansetron-8 mg |
| Anti Cancer Medicine Type | Nausea & Vomiting |
Product Details:
| Minimum Order Quantity | 10 Stripe |
| Strength | 40 mg |
| Brand | Pylozol Tablet |
| Packaging Size | 10 x 10 Tablets |
| Composition | Esomeprazole-40 mg |
| Shelf life | 2 Year |
| Form | Tablet |
| Packaging Type | Alu Alu Strip packing |
| Drug Name | Esomeprazole Megnesium |
| Prescription/Non prescription | Non prescription |
Product Details:
| Packaging Type | Blister |
| Prescription/Non prescription | Prescription |
| Deals in | Third Party Manufacturing |
| Usage | Clinical, Hospital |
| Packaging Size | 120 Tablet |
| Medicine Type | Allopathic |
Additional Information:
Product Details:
| Usage | Clinical, Hospital |
| Packaging Size | 30 Tablet |
| Packaging Type | Strip |
| Medicine Type | Allopathic |
| Application | Anti Cancer |
| Brand | Cipla |
Additional Information:
Product Details:
| Minimum Order Quantity | 30 Bottle |
| Packaging Type | Plastic Bottle |
| Usage | Clinical, Hospital |
| Packaging Size | 30 Tablets |
| Strength | 200 mg |
| Brand | Cipla |
Lenalidomide 10 mg Capsule is an oral immunomodulatory anticancer medicine used mainly in the treatment of blood-related cancers. It is commonly prescribed as part of combination therapy under strict medical supervision.
Key Features
Active Ingredient: Lenalidomide
Strength: 10 mg
Dosage Form: Capsule
Drug Class: Immunomodulatory agent (IMiD)
Route of Administration: Oral
Indications
Multiple Myeloma
Myelodysplastic Syndromes (MDS) with deletion 5q
Mantle Cell Lymphoma (in selected cases)
Mechanism of Action
Lenalidomide enhances immune system activity, inhibits abnormal blood vessel growth, and directly induces cancer cell death, helping control disease progression.
Storage
Store below 25°C
Protect from moisture and light
Safety
Teratogenic: strict pregnancy prevention measures required
Regular blood monitoring advised
Fosaprepitant Dimeglumine Injection is an antiemetic medication used to prevent chemotherapy-induced nausea and vomiting (CINV). It is a prodrug of aprepitant and is administered intravenously.
Key Features
Active Ingredient: Fosaprepitant Dimeglumine
Drug Class: Neurokinin-1 (NK1) receptor antagonist
Dosage Form: Powder for injection
Route of Administration: Intravenous infusion
Indications
Prevention of acute and delayed nausea and vomiting associated with highly and moderately emetogenic chemotherapy
Mechanism of Action
It blocks substance P at NK1 receptors in the brain, preventing vomiting signals triggered by chemotherapy.
Benefits
Single-dose IV administration
Improves patient comfort during chemotherapy
Storage
Store below 25°C
Reconstituted solution to be used as directed
Sorafenib 200 mg Tablet is an oral targeted anticancer medication used for the treatment of advanced cancers. It belongs to the class of multikinase inhibitors.
Key Features
Active Ingredient: Sorafenib
Strength: 200 mg
Dosage Form: Tablet
Drug Class: Tyrosine kinase inhibitor
Route of Administration: Oral
Indications
Advanced Hepatocellular Carcinoma (Liver Cancer)
Renal Cell Carcinoma (Kidney Cancer)
Differentiated thyroid carcinoma (in selected cases)
Additional Information:
Product Details:
| Usage | Hospital, Clinical |
| Packaging Size | 30 Tablet |
| Packaging Type | Strip |
| Medicine Type | Allopathic |
| Application | Anti Cancer |
| Brand | Cipla |
Erlotinib 150 mg Tablet is an oral targeted anticancer medication used mainly for the treatment of certain types of non-small cell lung cancer (NSCLC) and pancreatic cancer. It belongs to the class of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors.
Key FeaturesActive Ingredient: Erlotinib
Strength: 150 mg
Dosage Form: Tablet
Drug Class: EGFR tyrosine kinase inhibitor
Route of Administration: Oral
Non-Small Cell Lung Cancer (NSCLC) with EGFR-activating mutations
Pancreatic cancer (in combination with gemcitabine, in selected cases)
Used as first-line or maintenance therapy as prescribed by an oncologist
Erlotinib blocks the EGFR tyrosine kinase, which is involved in cancer cell growth and survival. By inhibiting this pathway, it helps slow or stop the proliferation of cancer cells.
BenefitsTargeted therapy with selective action on cancer cells
Convenient once-daily oral dosing
Effective in patients with EGFR-positive tumors
Taken once daily on an empty stomach (at least 1 hour before or 2 hours after food)
Tablets should be swallowed whole with water
Dose adjustments may be required based on tolerance and liver function
Store below 25°C
Protect from moisture and direct sunlight
Keep out of reach of children
Common side effects include skin rash, diarrhea, fatigue, and loss of appetite
Smoking reduces erlotinib effectiveness and should be avoided
Liver function and skin reactions should be monitored regularly
Additional Information:
Product Details:
| Minimum Order Quantity | 10 strip |
| Brand Name | Cosalon |
| Manufacturer | Cosalon 50mg |
| Packaging Size | 1*10 tab |
| Packaging Type | Strips |
| Type Of Medicines | Allopathic |
| Dose | 50 mg |
| Brand | Celon Labs |
| Prescription/Non prescription | Prescription |
| Pack Size | 10*10 Tablet |
Bicalutamide 50 mg Tablet is an oral anticancer medication used in the management of prostate cancer. It belongs to the class of non-steroidal anti-androgens and is commonly used as part of hormone (androgen deprivation) therapy.
Key FeaturesActive Ingredient: Bicalutamide
Strength: 50 mg
Dosage Form: Tablet
Drug Class: Non-steroidal anti-androgen
Route of Administration: Oral
Advanced or metastatic prostate cancer
Used in combination with LHRH analogues (medical castration) or following surgical castration
Helps control disease progression by blocking male hormones
Bicalutamide works by blocking androgen receptors, preventing testosterone and other androgens from stimulating prostate cancer cell growth. This slows tumor growth and helps manage cancer symptoms.
BenefitsEffective hormonal therapy for prostate cancer
Oral, once-daily dosing for convenience
Improves disease control when used in combination therapy
Usually taken once daily, with or without food
Dose and duration are determined by the treating oncologist
Tablets should be swallowed whole with water
Store below 25°C
Keep in a dry place away from direct sunlight
Keep out of reach of children
Common side effects include hot flashes, breast tenderness or enlargement (gynecomastia), fatigue, and nausea
Liver function should be monitored during treatment
Use only under medical supervision
Additional Information: